Wind prediction for wind farms through the use of weather radar
    1.
    发明授权
    Wind prediction for wind farms through the use of weather radar 有权
    通过使用气象雷达对风电场的风力预测

    公开(公告)号:US08606418B1

    公开(公告)日:2013-12-10

    申请号:US13051787

    申请日:2011-03-18

    IPC分类号: G05D3/12 G06F15/18

    摘要: A control system is provided. The control system comprises an electronic processor configured to control operation of at least one wind turbine. The control system further comprises at least one weather radar unit positioned proximate to the at least one wind turbine and configured to generate weather data. The electronic processor is configured to control the operation of the at least one wind turbine based on the weather data generated by the at least one weather radar unit.

    摘要翻译: 提供控制系统。 控制系统包括被配置为控制至少一个风力涡轮机的操作的电子处理器。 所述控制系统还包括至少一个位于所述至少一个风力涡轮机附近并被配置为产生天气数据的天气雷达单元。 电子处理器被配置为基于由至少一个天气雷达单元产生的天气数据来控制至少一个风力涡轮机的操作。

    Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF
and/or PDGF receptor tyrosine kinase
    7.
    再颁专利
    Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase 失效
    抑制EGF和/或PDGF受体酪氨酸激酶的双单和双环芳基和杂芳基化合物

    公开(公告)号:USRE36256E

    公开(公告)日:1999-07-20

    申请号:US988005

    申请日:1997-12-10

    摘要: This invention relates to bis mono- and/or bicyclic aryl and/or heteroaryl compounds exhibiting protein tyrosine kinase inhibition activity. More specifically, it relates to the method of inhibiting abnormal cell proliferation in a patient suffering from a disorder characterized by such proliferation comprising the administration thereto of an EGF and/or PDGF receptor inhibiting effective amount of said bis mono- and/or bicyclic aryl and/or heteroaryl compound and to the preparation of said compounds and their use in pharmaceutical compositions used in this method.

    摘要翻译: 本发明涉及显示蛋白酪氨酸激酶抑制活性的双单和/或双环芳基和/或杂芳基化合物。 更具体地,本发明涉及抑制患有以这种增殖为特征的病症的患者的异常细胞增殖的方法,其包括给予EGF和/或PDGF受体抑制有效量的所述双 - 单 - 和/或双环芳基和 /或杂芳基化合物,以及所述化合物的制备及其在该方法中使用的药物组合物中的用途。

    Installation tool for irrigation emitter barbs
    8.
    发明授权
    Installation tool for irrigation emitter barbs 失效
    灌溉发射倒钩安装工具

    公开(公告)号:US5893201A

    公开(公告)日:1999-04-13

    申请号:US923908

    申请日:1997-09-04

    申请人: Michael R. Myers

    发明人: Michael R. Myers

    摘要: A tool is provided for use in installing irrigation barb emitters in irrigation tubing. The tool comprises a cradle member having a cradle handle and a cradle jaw on opposing ends and a barb holder member having a barb holder handle and a barb holder jaw on opposing ends. The cradle member and the barb holder member are arranged in crossed relation. A cradle mounted on the cradle jaw is suitable for receiving a peripheral portion of an irrigation tubing. A barb holder mounted on the barb holder jaw is a hollow cylindrical cavity formed by two opposing barb holder jaw members. The barb holder has an axis aligned with the cradle with the opposing barb holder jaw members forming a slot opening therebetween. The slot opening is sized to allow snap fitting of the hollow cylinder of a barb emitter laterally into the hollow cylindrical cavity. A shoulder is formed by the lower edges of the opposing jaw members and acts against an annular disk shoulder on a barb emitter to force a piercing point on the barb emitter to penetrate irrigation tubing held within the cradle when the cradle jaw and the barb holder jaw are brought together. The barb emitter is released from the barb holder and retained within the irrigation tubing upon movement of the barb holder away from the cradle.

    摘要翻译: 提供了一种用于在灌溉管道中安装灌溉倒钩发射器的工具。 该工具包括一个支架构件,它具有支架把手和相对端部上的托架夹爪,以及在相对端部具有倒钩保持器手柄和倒钩保持夹爪的倒钩保持器构件。 托架构件和倒钩保持构件以交叉的关系布置。 安装在支架颚上的支架适用于接收冲洗管的周边部分。 安装在倒钩保持夹爪上的倒钩保持架是由两个相对的倒钩保持夹爪构件形成的中空圆柱形空腔。 倒钩保持器具有与支架对准的轴线,相对的倒钩保持器夹爪构件在其间形成狭槽开口。 狭槽开口的尺寸设计成允许倒钩发射器的中空圆柱体侧向地嵌入中空圆柱形空腔中。 肩部由相对的钳口构件的下边缘形成并且作用在倒钩发射器上的环形盘肩上,以在支架夹爪和倒钩保持器夹爪处迫使冲击发射器上的穿刺点穿过保持在支架内的冲洗管道 被带到一起 倒钩发射器从倒钩支架释放并在倒钩支架远离支架移动时保持在冲洗管道内。

    Compounds having antihypertensive, cardioprotective, anti-ischemic and
antilipolytic properties
    9.
    发明授权
    Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties 失效
    具有抗高血压,心脏保护作用,抗缺血性和抗脂解性的化合物

    公开(公告)号:US5561134A

    公开(公告)日:1996-10-01

    申请号:US316761

    申请日:1994-10-03

    摘要: Compounds of the Formula ##STR1## wherein: K is N or N.fwdarw.O; Q is CH.sub.2 or O; T is ##STR2## or R.sub.3 O--CH.sub.2 ; X is a straight or branched chain alkylene, cycloalkylene or cycloalkenylene group, each of which is optionally substituted by at least one CH.sub.3, CH.sub.3 CH.sub.2, Cl, F, CF.sub.3 or CH.sub.3 O; Y is NR.sub.4, O or S; a=0 or 1; Z is of the formula ##STR3## Z.sub.1 is N, CR.sub.5, (CH).sub.m --CR.sub.5 or (CH).sub.m --N, m being 1 or 2; Z.sub.2 is N, NR.sub.6, O or S, n being 0 or 1; R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5 and R.sub.6 are independently H, alkyl, aryl or heterocyclyl; R.sub.a and R.sub.b are independently H, OH, alkyl, hydroxyalkyl, alkyl mercaptyl, thioalkyl, alkoxy, alkyoxyalkyl, amino, alkyl amino, carboxyl, acyl, halogen, carbamoyl, alkyl carbamoyl, aryl or heterocyclyl; and R' and R" are independently hydrogen, alkyl, aralkyl, carbamoyl, alkyl carbamoyl, dialkylcarbamoyl, acyl, alkoxycarbonyl aralkoxycarbonyl, aryloxycarbonyl, or R' and R" together may form ##STR4## where R.sub.c is hydrogen or alkyl, ##STR5## where R.sub.d and R.sub.e are independently hydrogen, alkyl, or together with the carbon atom to which they are attached may form a 1,1-cycloalkyl group; provided that when X is straight chain alkylene and Q is oxygen, then Z represents a heterocyclyl including at least two heteroatoms, which are adenosine agonists useful as antihypertensive, cardioprotective, antiischemic, and antilipolytic agents, pharmaceutical compositions including such compounds, and their use in treating hypertension, myocardial ischemia, ameliorating ischemic injury and myocardial infarct size consequent to myocardial ischemia, hyperlipidemia and hypercholesterolemia are claimed.

    摘要翻译: 式的化合物其中:K为N或N-> O; Q是CH 2或O; T为或R3O-CH2; X是直链或支链亚烷基,亚环烷基或环亚烯基,其各自任选被至少一个CH 3,CH 3 CH 2,Cl,F,CF 3或CH 3 O取代; Y为NR4,O或S; a = 0或1; Z为式(Ⅰ)Z1为N,CR5,(CH)m-CR5或(CH)m-N,m为1或2; Z2为N,NR6,O或S,n为0或1; R1,R2,R3,R4,R5和R6独立地为H,烷基,芳基或杂环基; R a和R b独立地是H,OH,烷基,羟基烷基,烷基硫醇基,硫代烷基,烷氧基,烷氧基烷基,氨基,烷基氨基,羧基,酰基,卤素,氨基甲酰基,烷基氨基甲酰基,芳基或杂环基。 并且R'和R“独立地是氢,烷基,芳烷基,氨基甲酰基,烷基氨基甲酰基,二烷基氨基甲酰基,酰基,烷氧基羰基芳烷氧基羰基,芳氧基羰基或R'和R”可一起形成其中R c是氢或烷基, 其中Rd和Re独立地是氢,烷基或与它们所连接的碳原子一起形成1,1-环烷基; 条件是当X是直链亚烷基并且Q是氧时,Z代表包括至少两个杂原子的杂环基,它们是可用作抗高血压,心脏保护,抗缺血和抗脂肪分解剂的腺苷激动剂,包括这些化合物的药物组合物,以及它们在 要求治疗高血压,心肌缺血,改善缺血性损伤和心肌缺血,高脂血症和高胆固醇血症引起的心肌梗死面积。